195 related articles for article (PubMed ID: 7583902)
1. [Fatal hepatic necrosis during treatment with sodium valproate].
Miguil M; Chlihi A; Mjahed K; Sarf I; Moutawakkil S; Benaguida M
Cah Anesthesiol; 1995; 43(3):325-6. PubMed ID: 7583902
[TBL] [Abstract][Full Text] [Related]
2. [Fatal hepatic failure in a normally developed 5-year-old boy caused by VPA monotherapy].
König S; Scheffner D; Rauterberg-Ruland I; Kochen W; Hofmann WJ; Wokittel E; Schick U
Monatsschr Kinderheilkd; 1987 Jun; 135(6):310-3. PubMed ID: 3112563
[TBL] [Abstract][Full Text] [Related]
3. Fatal fulminant hepatic failure due to sodium valproate in an adolescent.
Puri AS; Sharma BC; Khan EM; Saraswat VA
Indian Pediatr; 1994 Feb; 31(2):207-10. PubMed ID: 7875849
[No Abstract] [Full Text] [Related]
4. Hepatic encephalopathy precipitated by sodium valproate therapy.
Subhash HS; Heddle RJ; Schultz DW; Ring J; Thompson CH
Med J Aust; 2008 May; 188(9):549. PubMed ID: 18459937
[No Abstract] [Full Text] [Related]
5. [Acute fatal liver insufficiency due to valproic acid therapy].
Binek J; Hany A; Egloff B; Heer M
Schweiz Med Wochenschr; 1991 Feb; 121(7):228-33. PubMed ID: 2008603
[TBL] [Abstract][Full Text] [Related]
6. Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults.
König SA; Schenk M; Sick C; Holm E; Heubner C; Weiss A; König I; Hehlmann R
Epilepsia; 1999 Jul; 40(7):1036-40. PubMed ID: 10403231
[TBL] [Abstract][Full Text] [Related]
7. Treatment of valproic acid-associated hepatic failure with orthotopic liver transplantation.
Bell EA; Shaefer MS; Markin RS; Wood RP; Langnas AN; Stratta RJ; Shaw BW
Ann Pharmacother; 1992 Jan; 26(1):18-21. PubMed ID: 1606338
[TBL] [Abstract][Full Text] [Related]
8. Valproate treatment after liver transplant in a patient with Lennox-Gastaut syndrome.
Velizarova R; Gelisse P; Pageaux GP; Genton P; Crespel A
Seizure; 2011 Jul; 20(6):500-1. PubMed ID: 21376637
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid hepatic fatalities. III. U.S. experience since 1986.
Bryant AE; Dreifuss FE
Neurology; 1996 Feb; 46(2):465-9. PubMed ID: 8614514
[TBL] [Abstract][Full Text] [Related]
10. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
Lackmann GM
Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
[TBL] [Abstract][Full Text] [Related]
11. [Hemorrhagic shock and fulminant hepatic failure associated with valproate].
Fernandez-Fernandez FJ; Garcia-Rego J; Garcia-Jimenez A; Sesma P
An Med Interna; 1995 Dec; 12(12):606-8. PubMed ID: 8679806
[TBL] [Abstract][Full Text] [Related]
12. [Valproate-associated hepatotoxicity--pathogenesis, clinical aspects, therapy and prevention].
Siemes H; Nau H
Klin Padiatr; 1991; 203(6):411-9. PubMed ID: 1758143
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid-induced encephalopathy in very long course treated patients.
Rousseau MC; Montana M; Villano P; Catala A; Blaya J; Valkov M; Allouard Y; Bugni E
Brain Inj; 2009 Nov; 23(12):981-4. PubMed ID: 19831495
[TBL] [Abstract][Full Text] [Related]
14. Fatal hepatocerebral syndrome in siblings discordant for exposure to valproate.
Lenn NJ; Ellis WG; Washburn ER; Ruebner B
Epilepsia; 1990; 31(5):578-83. PubMed ID: 2119302
[TBL] [Abstract][Full Text] [Related]
15. Fatal liver failure in 16 children with valproate therapy.
Scheffner D; König S; Rauterberg-Ruland I; Kochen W; Hofmann WJ; Unkelbach S
Epilepsia; 1988; 29(5):530-42. PubMed ID: 3137017
[TBL] [Abstract][Full Text] [Related]
16. A suspected case of late-onset sodium-valproate-induced hepatic failure.
van Egmond H; Degomme P; de Simpel H; Dierick AM; Roels H
Neuropediatrics; 1987 May; 18(2):96-8. PubMed ID: 3110642
[TBL] [Abstract][Full Text] [Related]
17. [Hyperammonemic encephalopathy associated with valproate acid].
Osuna MT; Burcet J; Ramió L; Ustrell X; Silva Y; Molins A
Neurologia; 2003; 18(6):347-50. PubMed ID: 12838456
[TBL] [Abstract][Full Text] [Related]
18. Valproate-associated carnitine deficiency and malignant cerebral edema in the absence of hepatic failure.
Triggs WJ; Gilmore RL; Millington DS; Cibula J; Bunch TS; Harman E
Int J Clin Pharmacol Ther; 1997 Sep; 35(9):353-6. PubMed ID: 9314085
[TBL] [Abstract][Full Text] [Related]
19. Valproate induced hyperammonemic encephalopathy successfully treated with levocarnitine.
Rigamonti A; Lauria G; Grimod G; Bianchi G; Salmaggi A
J Clin Neurosci; 2014 Apr; 21(4):690-1. PubMed ID: 24119342
[TBL] [Abstract][Full Text] [Related]
20. Valproate hepatotoxicity: a review and report of two instances in adults.
Dickinson RG; Bassett ML; Searle J; Tyrer JH; Eadie MJ
Clin Exp Neurol; 1985; 21():79-91. PubMed ID: 3939614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
